Lichen International (LICN) Fundamental Analysis: Revenue, Earnings & Valuation

9.28 / 10

Outperform

Fundamentals are rated Outperform with a 9.3/10 quality. Key strengths are operating cash‑flow margin, diluted EPS growth and net profit growth. Weaknesses lie in high liability‑to‑equity ratios, limiting the score but overall fundamentals remain robust.

Analysis Checks(5/8)

Shareholders’ equity attributable to parent company / Total liabilities (%)

Value21.74

Score0/3

Weight-35.97%

1M Return-2.23%

ROE (diluted) (YoY growth rate %)

Value-14.71

Score3/3

Weight72.06%

1M Return3.16%

Equity ratio (Total liabilities / Shareholders’ equity attributable to parent company) (%)

Value0.05

Score0/3

Weight-34.06%

1M Return-2.10%

Net cash flow from operating activities / Operating revenue (%)

Value-13.00

Score2/3

Weight38.12%

1M Return1.99%

Basic earnings per share (YoY growth rate %)

Value-819.73

Score2/3

Weight20.54%

1M Return1.05%

Net cash flow from operating activities (YoY growth rate %)

Value-150.28

Score1/3

Weight-0.81%

1M Return-0.04%

Diluted earnings per share (YoY growth rate %)

Value-819.73

Score2/3

Weight30.86%

1M Return1.56%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value-1319.82

Score2/3

Weight9.25%

1M Return0.49%

Is LICN fundamentally strong?

LICN scores 9.28/10 on fundamentals and holds a Discounted valuation at present. Backed by its -13.38% ROE, -42.69% net margin, -5.62 P/E ratio, 1.42 P/B ratio, and -222.73% earnings growth, these metrics solidify its Outperform investment rating.